Benjamin Vandendriessche, PhD, Chief Executive Officer of the Digital Medicine Society (DiMe)
On October 15, the Medical Affairs Professional Society will host its Technology and Innovation Symposium, with a keynote address delivered by Digital Medicine Society CEO Benjamin Vandendriessche.
AI is transforming the expectations that physicians, payers, and patients hold for Medical Affairs, and the field stands poised to take charge of this shift.”— Travis Hege, CEO of MAPSBOSTON, MA, UNITED STATES, October 2, 2026 /EINPresswire.com/ — As artificial intelligence transitions from experimental pilots to standard practice throughout the life sciences sector, the Medical Affairs Professional Society (MAPS) is set to assemble leaders from pharmaceutical, biotechnology, and medical device companies for the 2026 Medical Affairs Technology and Innovation Symposium, scheduled for Thursday, October 15, at One Boston Place in the heart of Boston. REGISTRATION IS NOW OPEN.
Organized by the MAPS New England Chapter and backed by sponsors Indegene and ACTO, the event will delve into how Medical Affairs teams can utilize AI, digital health tools, and data science to bring enhanced value to physicians, patients, and their companies—while ensuring responsible implementation.
"AI is reshaping the demands placed on Medical Affairs by physicians, payers, and patients, creating a genuine opening for the profession to steer this evolution," remarks Travis Hege, CEO of MAPS. “Our symposium gathers the individuals already deploying these technologies, ensuring participants walk away with actionable insights they can implement immediately."
The event kicks off with a keynote presentation by Benjamin Vandendriessche, PhD, Chief Executive Officer of the Digital Medicine Society (DiMe), entitled "Realizing the Promise of Digital Health: From Innovation to the Sustainable Transformation of Medicine."
Two Expert Panels on AI in Medical Affairs:
– From Promise to Performance: AI at Scale in Medical Affairs investigates the steps required to expand AI beyond trial phases into routine operations.
– Leading into the Future: Ethical Use Cases for AI and Data Science in Medical Affairs tackles the governance, transparency, and moral dilemmas confronting every Medical Affairs leader today.
Featured Panelists:
– Elnaz Alipour, Senior Director, Medical Analytics, Pfizer
– Gary Fanjiang, VP, US Medical Affairs, Amgen
– Lee Gervitz, Senior VP, Medical Affairs, Xenon Pharmaceuticals
– Parth Khanna, CEO and Founder, ACTO
– Jully Kim, Senior Director, Global Medical Operations, CSL
– Antonia Panayi, Head of Global Medical Evidence, Takeda
– Gem Roy, Associate Director, AI Enablement, Merck
To wrap up the day, a networking reception will provide attendees with the chance to interact with speakers and colleagues from throughout the Boston life sciences ecosystem.
Event Details:
– Date: Thursday, October 15, 2026
– Time: 12:30 – 7:30 PM ET
– Location: One Boston Place, 201 Washington Street, Boston, MA 02108
The symposium welcomes both MAPS members and non-members, with special pricing available for students.
About the Medical Affairs Professional Society (MAPS)
Established in 2016, the Medical Affairs Professional Society (MAPS) operates as a 501(c)(3) nonprofit and serves as the worldwide reference point for Medical Affairs professionals, linking more than 18,000 members globally in pharmaceuticals, biotech, MedTech, and related sectors. MAPS supports practitioners at every level, from newcomers to senior executives, via top-tier education, research-based insights, expert-led gatherings, and a worldwide network committed to advancing the discipline and molding its future. Additional information can be found at MedicalAffairs.org.
Craig Ruvere
Medical Affairs Professional Society
cruvere@medicalaffairs.org
Visit us on social media:
LinkedIn
YouTube
Also worth a look: Mitolyn, Built Around the Purple Peel Exploit, has been Launched, Designed to Enhance Mitochondrial Health & Manage Weight and Out Today: “My Favorite Things” by Award-winning Vocalist Nicole Henry.
